生物制药公司Ocular Therapeutix宣布,截至2026年3月31日,公司持有的现金及现金等价物总额为6.667亿美元。基于目前的资金状况和运营计划,公司预计现有资金足以支持其运营活动持续至2028年。
生物制药公司Ocular Therapeutix宣布,截至2026年3月31日,公司持有的现金及现金等价物总额为6.667亿美元。基于目前的资金状况和运营计划,公司预计现有资金足以支持其运营活动持续至2028年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.